Johnson & Johnson’s Joaquin Duato is no longer the highest paid CEO in pharma. Meanwhile, just two women make the top 10.

Pneumococcal conjugate vaccines, including more than seven serotypes, will have potential for a larger effect than PCV7 in many countries, including Norway. A 13-valent pneumococcal conjugate ...

Vaccine recommended to help protect persons over 10 years old in the United States (US) against disease-causing serogroups of Neisseria meningitidis (A, B, C, W, and Y) Broad serogroup coverage in ...

Applied in a vaccination program, the 7-valent pneumococcal conjugate vaccine (PCV7) in a 2+1 dose schedule appears to be highly effective. Conjugate vaccines with more than seven serotypes will ...

and W-135] Oligosaccharide Diphtheria CRM197 Conjugate Vaccine). in February 2025, the US Food and Drug Administration approved GSK's MenABCWY vaccine for use in individuals aged 10 through 25 years.

The ACIP voted that Penmenvy may be used as part of the adolescent meningococcal vaccination schedule as an alternative to separate administration of MenACWY and MenB. The Centers for Disease ...

Health and Human Services Secretary Robert F. Kennedy Jr. said the measles vaccine is "leaky" because its effectiveness wanes over time, something medical experts dispute. Kennedy, a vaccine ...

Many people have expressed worries about whether vitamin A can help prevent infection, whether they need a measles vaccine booster, or if measles can have long-term negative consequences on health.

A majority of the Centers for Disease Control and Prevention's work group on COVID-19 vaccines now supports ending the agency's pandemic-era recommendation for virtually all Americans to get ...